Press releases
- Dexcom Reports First Quarter 2024 Financial Results
- Dexcom Publishes Annual Sustainability Report
- Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
- Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter
- Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD
- Dexcom Announces Upcoming Conference Presentation
More ▼
Key statistics
On Wednesday, Dexcom Inc (DC4X:GER) closed at 119.02, -9.68% below its 52-week high of 131.78, set on Mar 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 116.42 |
---|---|
High | 119.02 |
Low | 115.50 |
Bid | 118.98 |
Offer | 119.42 |
Previous close | 115.34 |
Average volume | 99.00 |
---|---|
Shares outstanding | 397.68m |
Free float | 396.24m |
P/E (TTM) | 83.03 |
Market cap | 50.10bn USD |
EPS (TTM) | 1.52 USD |
Data delayed at least 15 minutes, as of May 15 2024 16:35 BST.
More ▼